Condition: Heart Failure and Reduced Ejection Fraction · NYHA Class III Heart Failure · Sponsor: Impulse Dynamics
The purpose of this prospective, multi-center, propensity-matched coverage with evidence development (CED) study is to assess the impact of cardiac contractility modulation (CCM) on mortality and heart failure hospitalizations in Medicare-eligible patients with heart failure who meet indications for CCM.
This description comes directly from the study's public registry record.
Kathy Sherwood, MBA · 856-642-9933 · ksherwood@impulsedynamics.com
Always discuss trial participation with your own doctor first.
| Impulse Dynamics | Marlton, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07209098